Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. (Q53237616)

12 May 2018

title

Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. (English)

1 reference

12 May 2018

author name string

Leake A

series ordinal

1

1 reference

12 May 2018

Morris CM

series ordinal

2

1 reference

12 May 2018

Whateley J

series ordinal

3

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

12 May 2018

number of pages

3

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

12 May 2018

volume

291

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

201-203

1 reference

12 May 2018

Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

beta-Amyloid induction of gelatinase B secretion in cultured microglia: inhibition by dexamethasone and indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Cerebral vessels in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Increased collagen content of cerebral microvessels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Senile dementia of Alzheimer type: astroglial reaction to extracellular neurofibrillary tangles in the hippocampus. An immunocytochemical and electron-microscopic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901418-X

7 January 2021

10.1016/S0304-3940(00)01418-X

Identifiers

DOI

1 reference

12 May 2018

release_sz26hrvnvjfhlpbergzlx57kum

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sz26hrvnvjfhlpbergzlx57kum

24 November 2022

mapped directly with Wikidata item

PubMed ID

10984641

1 reference

12 May 2018